Concepedia
Author
Ko Nakajo
Also Known As
K Nakajo, K. Nakajo, Ko Nakajo, Nakajo, Ko
27
Publications
427
Citations
9
H-Index
0
Concepts
All Affiliations
×
All Concepts
7
364
Efficacy and safety of ixekizumab treatment for Japanese patients with moderate to severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis: Results from a 52‐week, open‐label, phase 3 study (<scp>UNCOVER</scp>‐J)
Hidehisa Saeki, Hidemi Nakagawa, Ko Nakajo, +5
The Journal of Dermatology
2016
190
Long‐term efficacy and safety of ixekizumab in Japanese patients with erythrodermic or generalized pustular psoriasis: subgroup analyses of an open‐label, phase 3 study (<scp>UNCOVER</scp>‐J)
Yukari Okubo, Tomotaka Mabuchi, Keiji Iwatsuki, +4
Journal of the European Academy of Dermatology and Venereology
2018
62
Long‐term efficacy and safety results from an open‐label phase <scp>III</scp> study (<scp>UNCOVER</scp>‐J) in Japanese plaque psoriasis patients: impact of treatment withdrawal and retreatment of ixekizumab
Yoshinori Umezawa, Hitoe Torisu‐Itakura, Yoji Morisaki, +4
35
Transmissibility of asymptomatic COVID-19: Data from Japanese clusters
Ko Nakajo, Hiroshi Nishiura
International Journal of Infectious Diseases
2021
Efficacy and safety of 40 mg or 60 mg duloxetine in <scp>J</scp>apanese adults with diabetic neuropathic pain: Results from a randomized, 52‐week, open‐label study
Hitoshi Yasuda, Nigishi Hotta, Masato Kasuga, +6
Journal of Diabetes Investigation
2015
25
Assessing Interventions against Coronavirus Disease 2019 (COVID-19) in Osaka, Japan: A Modeling Study
Journal of Clinical Medicine
14
Trends in the prevalence and incidence of Crohn’s disease in Japan and the United States
Ko Nakajo, Michiyo Yamazaki, Hsingwen Chung, +2
International Journal of Colorectal Disease
2024
11
Page 1